{"organizations": [], "uuid": "5cf1ea9f3c0529f36e6b514f4b4c1560475df613", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/02/14/105008669-4ED3-PL-TIRELL-BMS-CANCER-DRUG-021418.600x400.jpg", "site_section": "http://www.cnbc.com/id/100004038/device/rss/rss.html", "section_title": "Latest Video", "url": "https://www.cnbc.com/video/2018/02/14/bristol-myers-inks-1-point-85-billion-cancer-drug-deal.html", "country": "US", "domain_rank": 767, "title": "Bristol-Myers inks $1.85 billion cancer drug deal", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-14T20:43:00.000+02:00", "replies_count": 0, "uuid": "5cf1ea9f3c0529f36e6b514f4b4c1560475df613"}, "author": "", "url": "https://www.cnbc.com/video/2018/02/14/bristol-myers-inks-1-point-85-billion-cancer-drug-deal.html", "ord_in_thread": 0, "title": "Bristol-Myers inks $1.85 billion cancer drug deal", "locations": [], "entities": {"persons": [{"name": "meg tirrell", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "cnbc", "sentiment": "negative"}, {"name": "nektar therapeutics", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Bristol-Myers inks $1.85 billion cancer drug deal 2 Hours Ago CNBC's Meg Tirrell looks at Bristol-Myers buying the drug testing rights for a cancer drug from Nektar Therapeutics.", "external_links": [], "published": "2018-02-14T20:43:00.000+02:00", "crawled": "2018-02-14T23:35:27.011+02:00", "highlightTitle": ""}